Antithrombotic therapy in peripheral artery disease

被引：14
|
作者：
Foley, T. Raymond
Waldo, Stephen W.
Armstrong, Ehrin J.
机构：
[1] Univ Colorado, VA Eastern Colorado Healthcare Syst, Denver, CO 80218 USA
[2] Univ Colorado, Div Cardiol, Denver, CO 80218 USA
来源：
VASCULAR MEDICINE | 2016年 / 21卷 / 02期
关键词：
anticoagulants; arterial occlusive diseases; intermittent claudication; critical limb ischemia; peripheral artery disease; platelet aggregation inhibitors; ACUTE CORONARY SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; PLACEBO-CONTROLLED TRIAL; ST-SEGMENT ELEVATION; INTERMITTENT CLAUDICATION; PLATELET ACTIVATION; ATHEROTHROMBOTIC EVENTS; CARDIOVASCULAR EVENTS;
D O I：
10.1177/1358863X15622987
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Antiplatelet agents are recommended for the reduction of major adverse cardiovascular events among all patients with symptomatic peripheral artery disease. However, the optimal antiplatelet regimen and duration of therapy in peripheral artery disease (PAD) remains unclear, largely due to limited and conflicting data in this patient population. This article reviews current data on antithrombotic therapy in PAD and discusses the implications of this data for current practice and future research.
引用
收藏
页码：156 / 169
页数：14
相关论文
共 50 条
  • [1] Antithrombotic Therapy for Peripheral Artery Disease
    Hussain, Mohamad A.
    Al-Omran, Mohammed
    Creager, Mark A.
    Anand, Sonia S.
    Verma, Subodh
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (21) : 2450 - 2467
  • [2] Antithrombotic therapy in peripheral artery disease
    Berger, Jeffrey S.
    [J]. LANCET, 2018, 391 (10117): : 183 - 184
  • [3] Antithrombotic therapy for peripheral artery occlusive disease
    Sobel, Michael
    Verhaeghe, Raymond
    [J]. CHEST, 2008, 133 (06) : 815S - 843S
  • [4] Antithrombotic Therapy in Patients With Peripheral Artery Disease
    Bonaca, Marc P.
    [J]. JAMA CARDIOLOGY, 2016, 1 (07) : 803 - 804
  • [5] Antithrombotic Therapy for Peripheral Artery Disease in 2018
    Hess, Connie N.
    Hiatt, William R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (22): : 2329 - 2330
  • [6] Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease
    Hess, Connie N.
    Bonaca, Marc P.
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (10) : E009584
  • [7] A comprehensive review on antithrombotic therapy for peripheral artery disease
    Gupta, Ryan
    Majumdar, Monica
    Imran, Rabbia
    Ii, Jeniann
    [J]. SEMINARS IN VASCULAR SURGERY, 2022, 35 (02) : 124 - 131
  • [8] Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction
    Kristin R. Hand
    Genevieve M. Hale
    [J]. American Journal of Cardiovascular Drugs, 2021, 21 : 523 - 534
  • [9] Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction
    Hand, Kristin R.
    Hale, Genevieve M.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 523 - 534
  • [10] Antithrombotic therapy in peripheral artery disease - antiplatelet therapy, anticoagulants, both or none
    Tangelder, Marco J. D.
    van Hattum, Eline S.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) : 196 - 199
12345